Rajiv Pandey

CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT.

Mosaic Technologies, Inc. offers research services in molecular diagnostics. It provides technical and public health-based assessment technologies. The company was founded by Christopher Adams in 1994 and is headquartered in Waltham, MA.

NAVIX Diagnostix, Inc. detects and diagnoses cardiovascular disease. The firm offers non-invasive heart and vascular diagnostic services, including vascular ultrasound, echocardiography, nuclear medicine and holter monitoring. Its services include credentialed technologists, clinical protocols, IAC lab accreditation (ICAVL, ICAEL and ICANL) consulting services, diagnostic equipment, risk-profiled stroke and vascular screening program, and other marketing programs. The company was founded in 1996 and is headquartered in Taunton, MA.

Part of Thermo Fisher Scientific, Inc., Pierce Biotechnology, Inc. is a company that offers a range of innovative, high-quality products for protein biology research. The company is based in Rockford, IL. The company's products include Pierce antibodies, SuperSignal chemiluminescent substrates, Pierce BCA protein assays, and other research tools and reagents.

AmberGen, Inc. provides label-free drug screening services, in-house mass spectrometric imaging services, and custom immunodiagnostics. The company is based in Watertown, MA. AmberGen is improving the accuracy of diagnostic tests with their allerbead™, a revolution in pediatric allergy testing, and their matrix effect and biomarker discovery. The company is transforming spatial biology with the power of mass spectrometry, offering no more limits with their multiplex, multiomic, multimodal, and whole slide technology. The company has developed and patented photocleavable linkers (pc linkers™), biomarker purification technology (pc pure™), and bead array mass spectrometry (bead ams™). With the power of bead ams™, they can perform label-free screening of drug protein interactions and screen lead drugs for off-target interactions. The company was founded by Kenneth Rothschild, and John Gillespie has been the CEO of the company since 2015.